AU2003303335A1 - Reduction of reactive oxygen species in chronic wound management - Google Patents
Reduction of reactive oxygen species in chronic wound management Download PDFInfo
- Publication number
- AU2003303335A1 AU2003303335A1 AU2003303335A AU2003303335A AU2003303335A1 AU 2003303335 A1 AU2003303335 A1 AU 2003303335A1 AU 2003303335 A AU2003303335 A AU 2003303335A AU 2003303335 A AU2003303335 A AU 2003303335A AU 2003303335 A1 AU2003303335 A1 AU 2003303335A1
- Authority
- AU
- Australia
- Prior art keywords
- solution
- ions
- wound
- weight
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43619702P | 2002-12-23 | 2002-12-23 | |
| US60/436,197 | 2002-12-23 | ||
| PCT/US2003/041038 WO2004057965A1 (en) | 2002-12-23 | 2003-12-23 | Reduction of reactive oxygen species in chronic wound management |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003303335A1 true AU2003303335A1 (en) | 2004-07-22 |
Family
ID=32682357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003303335A Abandoned AU2003303335A1 (en) | 2002-12-23 | 2003-12-23 | Reduction of reactive oxygen species in chronic wound management |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1575359A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006511585A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1744819A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003303335A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2511440A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004057965A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009251711B2 (en) * | 2008-04-01 | 2014-07-17 | Antipodean Pharmaceuticals, Inc. | Compositions and methods for skin care |
| WO2011022757A1 (en) * | 2009-08-24 | 2011-03-03 | Queensland University Of Technology | Purine-targeted diagnosis and therapy of wounds |
| WO2013016255A1 (en) * | 2011-07-28 | 2013-01-31 | 3M Innovative Properties Company | Wound-healing compositions and method of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3416777C2 (de) * | 1984-05-07 | 1986-11-20 | Gödecke AG, 1000 Berlin | Pharmazeutische topische Zubereitungen |
| DK0668769T3 (da) * | 1992-11-06 | 2000-10-02 | Greystone Medical Group Inc | Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse |
| NZ533252A (en) * | 2001-11-29 | 2006-03-31 | Greystone Medical Group Inc | Treatment of wounds and compositions employed |
-
2003
- 2003-12-23 WO PCT/US2003/041038 patent/WO2004057965A1/en not_active Ceased
- 2003-12-23 JP JP2004563981A patent/JP2006511585A/ja active Pending
- 2003-12-23 EP EP03808544A patent/EP1575359A4/en not_active Withdrawn
- 2003-12-23 CA CA002511440A patent/CA2511440A1/en not_active Abandoned
- 2003-12-23 AU AU2003303335A patent/AU2003303335A1/en not_active Abandoned
- 2003-12-23 CN CNA2003801095668A patent/CN1744819A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1575359A4 (en) | 2009-08-05 |
| JP2006511585A (ja) | 2006-04-06 |
| CN1744819A (zh) | 2006-03-08 |
| EP1575359A1 (en) | 2005-09-21 |
| CA2511440A1 (en) | 2004-07-15 |
| WO2004057965A1 (en) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080220091A1 (en) | Reduction of reactive oxygen species in chronic wound management | |
| Rotruck et al. | Prevention of oxidative damage to rat erythrocytes by dietary selenium | |
| Root et al. | The microbicidal mechanisms of human neutrophils and eosinophils | |
| Ferrari et al. | Occurrence of oxidative stress during myocardial reperfusion | |
| Kulkarni et al. | Studies on biochemical changes with special reference to oxidant and antioxidants in malaria patients | |
| Siegenthaler | Aging of the photosynthetic apparatus zIV. Similarity between the effects of aging and unsaturated fatty acids on isolated spinach chloroplasts as expressed by volume changes | |
| KONUKOGLU et al. | Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin | |
| Varma et al. | Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo | |
| Abubakar et al. | Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E | |
| Rosado et al. | Effects of reactive oxygen species on actin filament polymerisation and amylase secretion in mouse pancreatic acinar cells | |
| Mitchell et al. | Copper deficiency depresses rat aortae superoxide dismutase activity and prostacyclin synthesis | |
| Gay et al. | Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs | |
| Kim et al. | Effect of select antioxidants on malondialdehyde modification of proteins | |
| WO2004057965A1 (en) | Reduction of reactive oxygen species in chronic wound management | |
| González et al. | Diferulate and lignin formation is related tobiochemical differences of wall-bound peroxidases | |
| Gamaley et al. | Activation of murine macrophages by hydrogen peroxide | |
| Abu-Gharbieh et al. | Alleviation of Antioxidant Defense System by Ozonized Olive Oil in DNBS‐Induced Colitis in Rats | |
| Khatami et al. | Ascorbate regeneration in bovine ocular tissues by NADH-dependent semidehydroascorbate reductase | |
| Garcı́a-González et al. | Anti-inflammatory activity of Debaryomyces hansenii Cu, Zn-SOD | |
| Van der Zee et al. | The influence of ozone on human red blood cells. Comparison with other mechanisms of oxidative stress | |
| US5578300A (en) | Treatment of allergic contact dermatitis | |
| Bozhkov et al. | “Mix-Factor” is involved in the regulation of the organism's redox systems in the late stages of ontogenesis and affects the lifespan of animals | |
| Costantino et al. | Inhibitory activity of flavonols towards the xanthine oxidase enzyme | |
| Okabe et al. | Free radical damage to sarcoplasmic reticulum of masseter muscle by arachidonic acid and prostaglandin G2 | |
| Kazimierczak et al. | The mechanism of histamine release induced by the ionophore X537A from isolated rat mast cells: 1. Significance of Monovalent Cations, Calcium, Metabolic Energy and Temperature |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |